S100A7 and breast cancer: Otherwise, S100A7 promotes prosurvival pathways through increased activity of nuclear factor-κB and phospho-Akt and enhances invasive capability by augmenting epidermal growth factor receptor (EGFR) in ERα-negative breast cancer cells33, 34.